KEYTAKEAWAYS 5 to 11% of people on semaglutide report fatigue, with the highest rates seen in Wegovy usersThe first 4
Key Takeaways In the STEP clinical trials, approximately 3% of semaglutide users reported hair loss versus 1% on placebo. The
KEY TAKEAWAYSSemaglutide slows gastric emptying and whole-gut motility, causing constipation in up to 24% of people on higher doses.Symptoms are
One Drug. Three Products. Everything You Need to Know. Key Takeaways Semaglutide is a single molecule sold under three brand
Key Takeaways • Nausea, diarrhea, and vomiting are the most common Wegovy side effects, affecting up to 44% of users
Key Takeaways: Wegovy is semaglutide at a higher dose than Ozempic – FDA-approved specifically for weight loss, not diabetes. Clinical
Key Takeaways: Without exercise, research shows 25% to 60% of weight lost on Ozempic may come from muscle, not fat.
Key Takeaways Protein is your anchor. Aim for at least 0.8-1g protein per a kilogram of your body mass per
Key TakeawaysOzempic face is not caused by the drug itself. It results from rapid fat loss that outpaces the skin’s
Key TakeawaysOzempic (semaglutide) is a once-weekly injectable medicine approved in India by CDSCO for managing type 2 diabetes in adults.It
